Ha habido 50 transacciones internas recientes registradas para GlycoMimetics, Inc. (GLYC), incluyendo 36 compras y 14 ventas. El total de compras internas fue valorado en $6.73M y el total de ventas internas en $1.54M.
Internos destacados con actividad reciente incluyen Invus Public Equities, L.p., Siren, L.l.c., Rock Edwin. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — GLYC
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-08-08 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
260,873 |
$0.19 |
$50.01K |
6,317,565 |
| 2024-08-07 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
61,488 |
$0.18 |
$11.2K |
6,578,438 |
| 2024-08-06 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
55,732 |
$0.18 |
$10.19K |
6,639,926 |
| 2024-08-05 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
164,523 |
$0.19 |
$31K |
6,695,658 |
| 2024-08-02 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
286,200 |
$0.20 |
$57.35K |
6,860,181 |
| 2024-08-01 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
63,564 |
$0.22 |
$13.74K |
7,146,381 |
| 2024-07-30 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
756,835 |
$0.22 |
$167.18K |
7,209,945 |
| 2024-07-29 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
363,949 |
$0.24 |
$85.64K |
7,966,780 |
| 2024-07-26 |
Invus Public Equities, L.p. |
10 Percent Owner |
Venta Informativa |
258,335 |
$0.24 |
$62.44K |
8,330,729 |
| 2024-07-25 |
Siren, L.l.c. |
10 Percent Owner |
Disposición |
- |
- |
- |
8,589,064 |
| 2024-06-21 |
Rock Edwin |
Chief Medical Officer |
Compra Informativa |
115,000 |
$0.27 |
$30.72K |
680,403 |
| 2024-06-20 |
Rock Edwin |
Chief Medical Officer |
Compra Informativa |
190,000 |
$0.25 |
$48.11K |
565,403 |
| 2024-06-18 |
Hahn Brian M. |
SVP Finance, CFO |
Compra Informativa |
17,500 |
$0.25 |
$4.33K |
70,643 |
| 2024-05-01 |
Junius Daniel M |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Andrews Patricia S |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Pearson Timothy R |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Goldberg Mark Alan |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Jackson Scott Thomas |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
Koenig Scott |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-05-01 |
King Rachel K. |
Director |
Concesión de RSU |
40,000 |
$1.62 |
$64.8K |
40,000 |
| 2024-03-29 |
Junius Daniel M |
Director |
Concesión de RSU |
5,209 |
$3.00 |
$15.63K |
98,459 |
| 2024-03-29 |
Goldberg Mark Alan |
Director |
Concesión de RSU |
4,584 |
$3.00 |
$13.75K |
24,828 |
| 2024-03-29 |
King Rachel K. |
Director |
Concesión de RSU |
3,334 |
$3.00 |
$10K |
515,194 |
| 2024-01-12 |
Hahn Brian M. |
SVP Finance, CFO |
Concesión de RSU |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Semerjian Harout |
Chief Executive Officer |
Concesión de RSU |
695,000 |
$3.11 |
$2.16M |
695,000 |
| 2024-01-12 |
Rock Edwin |
Chief Medical Officer |
Concesión de RSU |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Rath Chinmaya |
SVP and Chief Business Officer |
Concesión de RSU |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2024-01-12 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
Concesión de RSU |
250,000 |
$3.11 |
$777.5K |
250,000 |
| 2023-12-29 |
Andrews Patricia S |
Director |
Concesión de RSU |
5,191 |
$2.36 |
$12.25K |
58,608 |
| 2023-12-29 |
Goldberg Mark Alan |
Director |
Concesión de RSU |
5,827 |
$2.36 |
$13.75K |
20,244 |
| 2023-12-29 |
King Rachel K. |
Director |
Concesión de RSU |
4,238 |
$2.36 |
$10K |
511,860 |
| 2023-09-30 |
Andrews Patricia S |
Director |
Concesión de RSU |
8,167 |
$1.50 |
$12.25K |
53,417 |
| 2023-09-30 |
Goldberg Mark Alan |
Director |
Concesión de RSU |
9,167 |
$1.50 |
$13.75K |
14,417 |
| 2023-09-30 |
King Rachel K. |
Director |
Concesión de RSU |
6,667 |
$1.50 |
$10K |
507,622 |
| 2023-09-22 |
Rock Edwin |
Chief Medical Officer |
Compra Informativa |
30,403 |
$1.38 |
$41.96K |
375,403 |
| 2023-09-21 |
Rock Edwin |
Chief Medical Officer |
Compra Informativa |
35,000 |
$1.38 |
$48.3K |
345,000 |
| 2023-06-01 |
Koenig Scott |
Director |
Ejercicio de Opciones (Venta) |
21,000 |
$0.60 |
$12.6K |
- |
| 2023-05-19 |
Junius Daniel M |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Andrews Patricia S |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Pearson Timothy R |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Goldberg Mark Alan |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Jackson Scott Thomas |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
Koenig Scott |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-19 |
King Rachel K. |
Director |
Concesión de RSU |
35,000 |
$1.98 |
$69.3K |
35,000 |
| 2023-05-17 |
Hahn Brian M. |
SVP Finance, CFO |
Venta Informativa |
3,700 |
$1.95 |
$7.22K |
53,143 |
| 2023-05-10 |
Junius Daniel M |
Director |
Compra Informativa |
30,000 |
$1.56 |
$46.8K |
93,250 |
| 2023-05-08 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
Compra Informativa |
13,500 |
$1.57 |
$21.2K |
138,980 |
| 2023-03-23 |
Rath Chinmaya |
SVP and Chief Business Officer |
Disposición |
150,000 |
$3.48 |
$522K |
- |
| 2023-03-23 |
Johnson Bruce S |
SVP & Chief Commercial Officer |
Disposición |
200,000 |
$2.55 |
$510K |
- |
| 2023-02-24 |
Invus Public Equities, L.p. |
10 Percent Owner |
Compra Informativa |
100,000 |
$1.70 |
$170K |
8,589,064 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
